181 related articles for article (PubMed ID: 8578817)
1. Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function.
Soltysik S; Wu JY; Recchia J; Wheeler DA; Newman MJ; Coughlin RT; Kensil CR
Vaccine; 1995; 13(15):1403-10. PubMed ID: 8578817
[TBL] [Abstract][Full Text] [Related]
2. Structure/function studies on QS-21, a unique immunological adjuvant from Quillaja saponaria.
Kensil CR; Soltysik S; Wheeler DA; Wu JY
Adv Exp Med Biol; 1996; 404():165-72. PubMed ID: 8957293
[No Abstract] [Full Text] [Related]
3. QS-21 structure/function studies: effect of acylation on adjuvant activity.
Liu G; Anderson C; Scaltreto H; Barbon J; Kensil CR
Vaccine; 2002 Jun; 20(21-22):2808-15. PubMed ID: 12034108
[TBL] [Abstract][Full Text] [Related]
4. Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses.
Newman MJ; Wu JY; Gardner BH; Munroe KJ; Leombruno D; Recchia J; Kensil CR; Coughlin RT
J Immunol; 1992 Apr; 148(8):2357-62. PubMed ID: 1373166
[TBL] [Abstract][Full Text] [Related]
5. QS-21 and QS-7: purified saponin adjuvants.
Kensil CR; Wu JY; Anderson CA; Wheeler DA; Amsden J
Dev Biol Stand; 1998; 92():41-7. PubMed ID: 9554258
[TBL] [Abstract][Full Text] [Related]
6. Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity.
Marciani DJ; Press JB; Reynolds RC; Pathak AK; Pathak V; Gundy LE; Farmer JT; Koratich MS; May RD
Vaccine; 2000 Jul; 18(27):3141-51. PubMed ID: 10856794
[TBL] [Abstract][Full Text] [Related]
7. Accessory cell requirements for saponin adjuvant-induced class I MHC antigen-restricted cytotoxic T-lymphocytes.
Wu JY; Gardner BH; Kushner NN; Pozzi LA; Kensil CR; Cloutier PA; Coughlin RT; Newman MJ
Cell Immunol; 1994 Apr; 154(1):393-406. PubMed ID: 7907530
[TBL] [Abstract][Full Text] [Related]
8. Advances in saponin-based adjuvants.
Sun HX; Xie Y; Ye YP
Vaccine; 2009 Mar; 27(12):1787-96. PubMed ID: 19208455
[TBL] [Abstract][Full Text] [Related]
9. Platycodin D2 is a potential less hemolytic saponin adjuvant eliciting Th1 and Th2 immune responses.
Xie Y; Deng W; Sun H; Li D
Int Immunopharmacol; 2008 Aug; 8(8):1143-50. PubMed ID: 18550019
[TBL] [Abstract][Full Text] [Related]
10. Development of Improved Vaccine Adjuvants Based on the Saponin Natural Product QS-21 through Chemical Synthesis.
Fernández-Tejada A; Tan DS; Gin DY
Acc Chem Res; 2016 Sep; 49(9):1741-56. PubMed ID: 27568877
[TBL] [Abstract][Full Text] [Related]
11. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex.
Kensil CR; Patel U; Lennick M; Marciani D
J Immunol; 1991 Jan; 146(2):431-7. PubMed ID: 1987271
[TBL] [Abstract][Full Text] [Related]
12. Acylated and deacylated quillaja saponin-21 adjuvants have opposite roles when utilized for immunization of C57BL/6 mice model with MOG
Heidari AR; Boroumand-Noughabi S; Nosratabadi R; Lavi Arab F; Tabasi N; Rastin M; Mahmoudi M
Mult Scler Relat Disord; 2019 Apr; 29():68-82. PubMed ID: 30685444
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant activity of QS-21 isomers.
Soltysik S; Bedore DA; Kensil CR
Ann N Y Acad Sci; 1993 Aug; 690():392-5. PubMed ID: 8368766
[TBL] [Abstract][Full Text] [Related]
14. The muramyl dipeptide analog GMTP-N-DPG preferentially induces cellular immunity to soluble antigens.
Fast DJ; Vosika GJ
Vaccine; 1997 Nov; 15(16):1748-52. PubMed ID: 9364678
[TBL] [Abstract][Full Text] [Related]
15. Structure and biological activity of protopanaxatriol-type saponins from the roots of Panax notoginseng.
Sun H; Yang Z; Ye Y
Int Immunopharmacol; 2006 Jan; 6(1):14-25. PubMed ID: 16332509
[TBL] [Abstract][Full Text] [Related]
16. Novel ISCOMs from Quillaja brasiliensis saponins induce mucosal and systemic antibody production, T-cell responses and improved antigen uptake.
Cibulski SP; Mourglia-Ettlin G; Teixeira TF; Quirici L; Roehe PM; Ferreira F; Silveira F
Vaccine; 2016 Feb; 34(9):1162-71. PubMed ID: 26826546
[TBL] [Abstract][Full Text] [Related]
17. Fractionation, structural studies, and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100.
Marciani DJ; Reynolds RC; Pathak AK; Finley-Woodman K; May RD
Vaccine; 2003 Sep; 21(25-26):3961-71. PubMed ID: 12922132
[TBL] [Abstract][Full Text] [Related]
18. Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine.
Wu JY; Gardner BH; Murphy CI; Seals JR; Kensil CR; Recchia J; Beltz GA; Newman GW; Newman MJ
J Immunol; 1992 Mar; 148(5):1519-25. PubMed ID: 1538134
[TBL] [Abstract][Full Text] [Related]
19. Effects of carbohydrate modification of Quillaja saponaria Molina QH-B fraction on adjuvant activity, cholesterol-binding capacity and toxicity.
Rönnberg B; Fekadu M; Behboudi S; Kenne L; Morein B
Vaccine; 1997 Dec; 15(17-18):1820-6. PubMed ID: 9413088
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Evaluation of QS-7-Based Vaccine Adjuvants.
Wang P; Škalamera Đ; Sui X; Zhang P; Michalek SM
ACS Infect Dis; 2019 Jun; 5(6):974-981. PubMed ID: 30920199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
